Japan
· Delayed Price · Currency is JPY Sawai Group Holdings Company Description
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.
The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs and anus, chemotherapeutic and antineoplastic agents, respiratory system, etc., as well as vitamin preparations.
It sells its generic drugs through distributors, wholesalers, and retailers in Japan and the United States.
Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.
| Country | Japan |
| Founded | 1929 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,482 |
| CEO | Mitsuo Sawai |
Contact Details
Address: 5-2-30, Miyahara Osaka, 532-0003 Japan | |
| Phone | 81 6 6105 5818 |
| Website | sawaigroup.holdings |
Stock Details
| Ticker Symbol | 4887 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3323040000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mitsuo Sawai | Chief Executive Officer |
| Jun Tsujii | Chief Financial Officer |
| Mitsuo Sawai | Chief Operating Officer |
| Yasushi Kora | Head of Investor Relations |